Trial intelligence / Profile preview

Donor Dopamine and Initial Graft Function

NCT00115115Phase 4Completed

Sponsor
Universitätsmedizin Mannheim
Start
Mar 2004
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dopamine in end stage renal disease (ESRD), sponsored by Universitätsmedizin Mannheim. Started Mar 2004; status: completed.

02

Drugs

dopamine
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT00115115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00115115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call